A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

Completed · Phase 2 · Has a placebo group

Conditions studied: Diabetes Mellitus Type 2

In brief

This study will assess the efficacy, safety and tolerability of DPP-IV Inhibitor compared to placebo in patients with type 2 diabetes. The anticipated time on study treatment is \< 3 months and the target sample size is 100-500 individuals.

Key facts

Study ID

NCT00111670

Run by

Hoffmann-La Roche

People needed

291

Starts

2005-06-01

Expected to finish

2006-07-01

Last updated by the study team

2016-11-02

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• adult patients 18-75 years of age;
• type 2 diabetes diagnosed >=1 month before screening;
• no previous treatment, or previous treatment with no more than 2 oral medications.

You may not qualify if…

• type 1 diabetes;
• type 2 diabetes treated with insulin or a PPAR gamma agonist during the 3 months before screening;
• patients who are pregnant, breastfeeding or not using a reliable contraceptive method.

Where it is running

• Study site — Salinas, California, United States
• Study site — Clearwater, Florida, United States
• Study site — Hialeah, Florida, United States
• Study site — Pembroke Pines, Florida, United States
• Study site — Blue Ridge, Georgia, United States
• Study site — Aurora, Illinois, United States
• Study site — Elkton, Maryland, United States
• Study site — Oxon Hill, Maryland, United States
• Study site — Troy, Michigan, United States
• Study site — Pahrump, Nevada, United States
• Study site — Cincinnati, Ohio, United States
• Study site — Portland, Oregon, United States
• Study site — Warminster, Pennsylvania, United States
• Study site — Dallas, Texas, United States
• Study site — Midland, Texas, United States
• Study site — San Antonio, Texas, United States
• Study site — Richmond, Virginia, United States
• Study site — Virginia Beach, Virginia, United States
• Study site — Rousse, Bulgaria
• Study site — Sofia, Bulgaria
• Study site — Sofia, Bulgaria
• Study site — San José, Costa Rica
• Study site — Tartu, Estonia
• Study site — Tartu, Estonia
• Study site — Ogre, Latvia

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.